The Outcomes of Living Donor Robotic Assisted Kidney Transplantation
Recruiting
Observational Study
Kidney Transplant; Complications
Renal Failure Chronic
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Observational
- Participants needed
- 400 (estimated)
- Sponsor
- West China Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The technology for robot-assisted kidney transplantation (RAKT) has become increasingly advanced, with numerous studies demonstrating comparable outcomes between RAKT surgery and open surgery. This advancement is particularly noteworthy as it extends its suitability to transplant patients with obesity. It will be important to explore the results of robot-assisted kidney transplantation as compared…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. living-donor kidney transplant recipients
2. receiving standard triad immunosuppressive regimen
Exclusion Criteria:
1. active infection
2. multi-organ transplantation
3. malignancy history in the donor and recipient
4. human immunodeficiency virus infection
Contacts